EpiPen makers to pay $465MILLION to settle questions over whether it underpaid Medicaid programs by misclassifying the emergency allergy treatment
- Mylan has been lambasted for raising prices on the lifesaving EpiPen sixfold to over $600 for a package of two in less than a decade
- Lawmakers were trying to determine if Mylan made more money than warranted from Medicaid by having EpiPen classified as a generic product
- They have contended that Mylan underpaid Medicaid rebates by misclassifying EpiPen as a generic instead of a branded drug
Mylan NV on Friday said it will pay $465million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases.
Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving EpiPen sixfold to over $600 for a package of two in less than a decade, making the devices unaffordable for a growing number of families.
Lawmakers were trying to determine whether Mylan made more money on EpiPen than warranted from state Medicaid programs by having it classified as a generic product, resulting in much smaller rebates to the government health plans.
Mylan NV on Friday said it will pay $465million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment
Mylan Chief Executive Heather Bresch was grilled by the House Committee on Oversight and Government Reform for the price increase and they were skeptical of her profit analysis of the product.
The Centers for Medicare and Medicaid Services, in response to a request from U.S. Senator Amy Klobuchar of Minnesota, said this week that the Medicaid plan for the poor spent $797 million on EpiPen between 2011 and 2015, including rebates provided by Mylan, or $960million before rebates.
Lawmakers have contended that Mylan underpaid Medicaid rebates by misclassifying EpiPen as a generic instead of a branded drug.
The Medicaid rebate for a generic is 13 per cent compared with a minimum 23.1 per cent for a branded drug.
'I am glad the Department of Justice pursued this so quickly,' Klobuchar said in a statement. 'If other drugs are misclassified, and surely EpiPen isn't the only one... the taxpayers need to get their money back.'
Senator Richard Blumenthal of Connecticut blasted the settlement as too small and said Congress should investigate whether Mylan violated the law.
'This settlement is a shadow of what it should be - lacking real accountability for Mylan's apparent lawbreaking,' he said in a statement.
Mylan Chief Executive Heather Bresch was grilled by the House Committee on Oversight and Government Reform for the price increase and they were skeptical of her profit analysis of the product
Mylan said in a regulatory filing on Friday that EpiPen will be classified as a branded drug as of April 1, 2017.
Bresch told lawmakers this week that Mylan plans to launch a $300 generic version of EpiPen as soon as possible this year.
Mylan also lowered its 2016 earnings outlook, but the drugmaker affirmed its 2018 forecast and its shares rose 11 per cent to $39.90 after hours.
'Kudos to management for fast action,' AB Bernstein analyst Ronny Gal said in a video message to investors. 'This was one of the major risks everyone was focusing on... now it is essentially off the table.'
Mylan said it will record a pretax charge of about $465million in the quarter ended September 30.
The company, which will make the payment to the Department of Justice and other government agencies, said the settlement does not include any finding of wrongdoing.
Mylan, citing changes to the EpiPen consumer discount program and upcoming launch of a generic version, said it now expects full-year 2016 adjusted earnings per share of $4.70 to $4.90, down from $4.85 to $5.15.
Mylan said it 'remains committed' to its target of at least $6.00 in adjusted earnings per share in 2018.
Most watched News videos
- CCTV captures final tragic moments of Mirna Salihin's life
- Mother shaves daughters hair after she 'bullies cancer girl'
- GRAPHIC CONTENT: 'Ghost' rises from body after fatal crash
- Bulls head butt each other then die instantly from brutal blow
- Shocking moment girl gets viciously beaten after starting fight
- Mother releases devastating footage of son's final moments
- Lorry smashes into car leaving driver with severe injuries
- Is this the creepy moment the corpse of a girl OPENS her eyes?
- 'Big fat gypsy wedding' in Romania goes on for FOUR days
- Groom ALREADY tired of marriage life just after 15 minutes
- 'Pascal's a G!' Kim Kardashian speaks well of her bodyguard
- GoPro captures the moment a croc swims amongst swimmers
- 'You can do anything. Grab them by the p***y': Donald Trump...
- Julian Assange warns WikiLeaks will expose Google as he...
- Tat looks painful! Tattoo fans from around the world flock...
- REVEALED: TV host Nancy O'Dell is the married woman who...
- Creepy clown gets beat up with a baseball bat when he tries...
- Charleston wakes up under water: Deadly Hurricane Matthew...
- Haiti's death toll nears 900 and is expected to rise into...
- 'She was gang-raped, beaten and shot dead': Parents speak...
- Fears for a huge flock of migrating birds which has been...
- Campaigners start White House petition calling for man who...
- 'Unacceptable and offensive': MELANIA condemns Trump's hot...
- Syrian migrant helps capture ISIS terrorist who tortured him...